Support our Foundation of Myology project
1655 news items
Exploring the infinitely small – Interview with Stéphane Vassilopoulos
On 16/06/2025
An expert in cell biology and molecular biology, Stéphane Vassilopoulos is co-director of the ‘Muscle cell organization and therapy of dominant centronuclear myopathy‘ team at…
Va-C-Nemus reassures on the safety of vaccination against Covid-19 in NMD
On 16/06/2025
Launched in 2021, the Va-C-Nemus national prospective observational study involved 1,020 adults with a neuromuscular disease of genetic or autoimmune origin, 18% of whom were…
M&M’s – Muscle Monday Seminar – 23 June – Eric Allemand (France)
On 16/06/2025
Regulation of transcriptome diversity through alternative splicing in hematological genetic disorders Monday 23 June 2025 – 12h00-13h00 Eric Allemand, PhD (Imagine Institute, Paris, France) More information on the…
Seeing our muscles in action – Interview with Constantin Slioussarenko
On 12/06/2025
Constantin Slioussarenko, an engineer by training, is a researcher in the NMR and Spectroscopy Laboratory, co-directed by Harmen Reyngoud and Benjamin Marty, at the Neuromuscular…
A look back at the 3rd edition of ‘Muscle Week’
On 12/06/2025
The 3ᵉ edition of Muscle Week, organised from 2 to 8 June 2025 by the Institute of Myology and AFM-Téléthon, mobilised researchers, healthcare professionals, the…
Building the Muscle Atlas – Interview with Bruno Cadot
On 11/06/2025
Bruno Cadot is head of research in the ‘Signalling pathways and striated muscles’ team led by Antoine Muchir at the Center of Research in Myology…
The evolution of the new Morimoto-Ruy-Malicdan syndrome described in two brothers
On 10/06/2025
In a previous study published in 2024, Marie Morimoto et al. described nine cases of a new congenital myopathy linked to biallelic variants of the…
Towards a reassessment of certain contraindications to the use of drugs in autoimmune myasthenia gravis
On 03/06/2025
American researchers have investigated the possible complications associated with the use of several classes of antibiotics known to be harmful to myasthenia gravis patients: data…
The association of dermatomyositis and encephalopathy is exceptional but should be noted
On 02/06/2025
Mexican clinicians report the clinical and immunological data of three patients with concomitant encephalopathy and dermatomyositis (DM): the three patients were adults in their fifties…
Rising incidence of motor neurone disease in France before the Covid-19 crisis
On 30/05/2025
Using data from the French National Health Data System (SNDS), a French team has carried out a study of changes in the incidence of motor…
No additional long-term beneficial effects for the bisoprolol-perindopril combination
On 28/05/2025
British clinicians report the long-term results of a prophylactic treatment for cardiomyopathy in Duchenne muscular dystrophy (DMD): the combination of perindopril (a conversion enzyme inhibitor)…
Advances in myasthenia gravis – 2025
On 28/05/2025
This document presents a selection of myasthenia gravis research news stories from the past year (ongoing observational studies and clinical trials, scientific and medical publications…).…
Variable severity of SMA in patients with four copies of the SMN2 gene
On 27/05/2025
A study published using data from the SMA France register, set up in 2020, shows a wide variety of phenotypes in patients with SMN1-related proximal…
Towards conditional authorisation of givinostat in Europe for walking DMD patients aged 6 and over on corticosteroids
On 26/05/2025
Givinostat, a histone deacetylase (HDAC) inhibitor that acts on muscle fibrosis and inflammation in Duchenne muscular dystrophy, should be authorised in Europe very soon, under…
A new non-invasive biomarker for investigating demyelinating neuropathies
On 23/05/2025
An international consortium led by researchers in Nantes has developed and studied in real life a new non-invasive method for demyelinating neuropathies such as CMT1A,…
A model to predict the distance covered during the 6MWT in Pompe disease
On 22/05/2025
Researchers from the Laboratory of Physiology and Neuromuscular Evaluation at the Institute of Myology have developed and validated predictive models for the performance of the…
ERN EURO-NMD webinar, 28 May: Dr. Nicol Voermans & Ria de Haas, PhD (the Netherlands)
On 22/05/2025
FSHD webinar series – Episode 4: “Clinical Trial Readiness” Wednesday 28 May 2025 – 16:00 – 17:00 Paris time Dr. Nicol Voermans & Ria de…
The Institute’s teams at the 5th International Meeting on Laminopathies from 21 to 23 May in Paris
On 21/05/2025
The 5th International Meeting on Laminopathies, being held in Paris from 21 to 23 May, brings together international experts in nuclear envelope proteins and associated…
A natural history study of upper limb function in SMA type II
On 20/05/2025
The Spanish network responsible for monitoring patients with SMN1-related proximal spinal muscular atrophy (SMA) retrospectively studied the evolution of upper limb function in SMA type…
M&M’s – Muscle Monday Seminar – 19 May – Aurélie Goyenvalle (France)
On 19/05/2025
Antisense approaches for the treatment of Duchenne muscular dystrophy and recent advances to address DMD brain comorbidities Monday 19 May 2025 – 12h00-13h00 Aurélie Goyenvalle,…